NO964032L - Kovalente dimerer av kit-ligand og FLT-3/FLK-2-ligand - Google Patents

Kovalente dimerer av kit-ligand og FLT-3/FLK-2-ligand

Info

Publication number
NO964032L
NO964032L NO964032A NO964032A NO964032L NO 964032 L NO964032 L NO 964032L NO 964032 A NO964032 A NO 964032A NO 964032 A NO964032 A NO 964032A NO 964032 L NO964032 L NO 964032L
Authority
NO
Norway
Prior art keywords
ligand
murine
kit
protein
fusion
Prior art date
Application number
NO964032A
Other languages
English (en)
Norwegian (no)
Other versions
NO964032D0 (no
Inventor
Karl H Nocka
Robert B Lobell
Original Assignee
Cytomed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytomed Inc filed Critical Cytomed Inc
Publication of NO964032D0 publication Critical patent/NO964032D0/no
Publication of NO964032L publication Critical patent/NO964032L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO964032A 1994-03-28 1996-09-25 Kovalente dimerer av kit-ligand og FLT-3/FLK-2-ligand NO964032L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/220,379 US5525708A (en) 1994-03-28 1994-03-28 Covalent dimer of kit ligand
PCT/US1995/003866 WO1995026199A1 (en) 1994-03-28 1995-03-28 Covalent dimers of kit ligand and flt-3/flk-2 ligand

Publications (2)

Publication Number Publication Date
NO964032D0 NO964032D0 (no) 1996-09-25
NO964032L true NO964032L (no) 1996-11-28

Family

ID=22823324

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964032A NO964032L (no) 1994-03-28 1996-09-25 Kovalente dimerer av kit-ligand og FLT-3/FLK-2-ligand

Country Status (10)

Country Link
US (1) US5525708A (de)
EP (1) EP0759767A1 (de)
JP (1) JPH09512706A (de)
AU (1) AU2199895A (de)
CA (1) CA2186496A1 (de)
FI (1) FI963900A7 (de)
HU (1) HU9602682D0 (de)
MX (1) MX9604394A (de)
NO (1) NO964032L (de)
WO (1) WO1995026199A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ314644A (en) 1993-05-24 2000-11-24 Immunex Corp Use of flt3-ligands as a growth stimulator of stem cells in the transplantation of tissue
US5554512A (en) * 1993-05-24 1996-09-10 Immunex Corporation Ligands for flt3 receptors
US6190655B1 (en) 1993-12-03 2001-02-20 Immunex Corporation Methods of using Flt-3 ligand for exogenous gene transfer
US7294331B2 (en) * 1994-03-07 2007-11-13 Immunex Corporation Methods of using flt3-ligand in hematopoietic cell transplantation
US7150992B1 (en) 1995-10-04 2006-12-19 Innunex Corporation Methods of preparing dendritic cells with flt3-ligand and antigen
US20020034517A1 (en) * 1995-10-04 2002-03-21 Kenneth Brasel Dendritic cell stimulatory factor
US7361330B2 (en) * 1995-10-04 2008-04-22 Immunex Corporation Methods of using flt3-ligand in the treatment of fibrosarcoma
US5885962A (en) * 1996-04-05 1999-03-23 Amgen Inc. Stem cell factor analog compositions and method
US6017527A (en) * 1996-07-10 2000-01-25 Immunex Corporation Activated dendritic cells and methods for their activation
KR20000022445A (ko) * 1996-07-10 2000-04-25 크리스토퍼 엘. 와이트, 스코트 지. 홀퀴스트, 스티븐 엘. 말라스카 수상돌기 세포의 활성화 방법
AU751498B2 (en) * 1997-04-11 2002-08-15 G.D. Searle & Co. flt3 ligand chimeric proteins
US20030022233A1 (en) * 1999-04-30 2003-01-30 Raymond G. Goodwin Methods of use of the taci/taci-l interaction
US20030077263A1 (en) * 1999-10-29 2003-04-24 Immunex Corporation Method of activating dendritic cells
ATE544463T1 (de) 2004-11-05 2012-02-15 Univ Northwestern Verwendung von scf und g-scf bei der behandlung von hirnischämie und neurologischen störungen
US8093046B2 (en) * 2006-05-31 2012-01-10 Philadelphia Health and Education Corporation d/b/c Drexel University College of Medicine CVN-12p1: a recombinant allosteric lectin antagonist of HIV-1 envelope gp120 interactions
NZ597580A (en) * 2009-07-20 2013-11-29 Univ Nat Taiwan Polypeptides selective for alpha.v.beta.3 integrin conjugated with a variant of human serum albumin (hsa) and pharmaceutical uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873191A (en) * 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
RU2212411C2 (ru) * 1989-10-16 2003-09-20 Эмджен Инк. Полипептид, обладающий гемопоэтической биологической активностью фактора стволовых клеток (варианты), днк (варианты), экспрессирующий вектор (варианты), фармацевтическая композиция для гемопоэтической терапии, способ получения полипептида и способ его использования (варианты)
DK0423980T3 (da) * 1989-10-16 2000-10-09 Amgen Inc Stamcellefaktor
WO1992000376A1 (en) * 1990-06-25 1992-01-09 Immunex Corporation Mast cell growth factor
US20030125519A1 (en) * 1990-08-27 2003-07-03 Peter Besmer Ligand for the c-kit receptor and methods of use thereof
US5199942A (en) * 1991-06-07 1993-04-06 Immunex Corporation Method for improving autologous transplantation
JPH07502263A (ja) * 1991-09-13 1995-03-09 ボロン．バイオロジカルス．インコーポレイテッド 有機ホウ素化合物を利用して、動物の骨粗鬆症及びその他の病気を治療する方法
DE69330878T2 (de) * 1992-04-23 2002-05-29 Sloan-Kettering Institute For Cancer Research, New York Ligand für den c-kit-rezepten und verfahren zu seiner nutzung
US5554512A (en) * 1993-05-24 1996-09-10 Immunex Corporation Ligands for flt3 receptors

Also Published As

Publication number Publication date
FI963900L (fi) 1996-11-27
HU9602682D0 (en) 1996-11-28
WO1995026199A1 (en) 1995-10-05
FI963900A0 (fi) 1996-09-27
MX9604394A (es) 1997-07-31
NO964032D0 (no) 1996-09-25
AU2199895A (en) 1995-10-17
FI963900A7 (fi) 1996-11-27
US5525708A (en) 1996-06-11
CA2186496A1 (en) 1995-10-05
EP0759767A1 (de) 1997-03-05
JPH09512706A (ja) 1997-12-22

Similar Documents

Publication Publication Date Title
ATE252113T1 (de) Verwendung von wnt polypeptiden
DK25489D0 (da) Fremgangsmaade til fremstilling af en secerneret human-pdgf-receptoranalog, en secerneret biologisk aktiv peptiddimer henholdsvis en secerneret ligandbindende receptoranalog samt farmaceutisk sammensaetning omfattende samme
DE69807679D1 (de) Zusammensetzungen aus konjugaten des stabilen, aktiven, menschlichen ob proteins mit der fc kette von immunoglobulinen und damit zusammenhängende verfahren
DK0790255T3 (da) Monoklonale antistoffer som er rettet mod den cytotoksiske lymfocytmodningsfaktor
DK0506826T3 (da) Antistofantagonister mod humant interleukin-4
CY1107821T1 (el) Πολυπεπτιδιο παραγοντα viii με ενεργοτητα παραγοντα viii:c
DE69637570D1 (de) Varianten des wachstumsfaktors der vaskulären endothelzellen, ihre verwendung sowie methoden für ihre herstellung
ATE110276T1 (de) Blutersatz.
ATE112573T1 (de) Inhibin und dessen reinigung.
DE59109032D1 (de) Fusionsproteine mit immunglobulinanteilen, ihre Herstellung und Verwendung
ATE125869T1 (de) Wachstumshormonfusionsproteine.
ATE153858T1 (de) Ligand für das neu-gen-produkt
DE69132275D1 (de) Beta-type ähnlicher transformierender wachstumfaktor
MY102806A (en) Human interleukin-3 and muteins thereof
SI1511770T1 (sl) Glikoprotein VI-Fc fuzijski protein za zdravljenje vaskularnih bolezni
ATE294236T1 (de) Promotor der tie rezeptor protein kinase
DE69939330D1 (de) Wachstumsfaktor-homologe zvegf-3
KR920703134A (ko) 생유기체의 생물부, 특히 기관을 생성하기 위한 활성물질 복합체, 이를 제조하는 방법 및 이의 용도
MX9604394A (es) Dimeros covalentes del ligando kit y del ligando flt-3/flk-2.
DE68928710D1 (de) T-Zellen-Wachstumsfaktor
MX9203879A (es) Muteina de il-6 con cisteina parcialmente suprimida.
TR199802584T2 (xx) Denat�re proteinin aktive edilmesi i�in y�ntem.
ATE124539T1 (de) Immunogen und seine verwendung zur gewinnung von antikörpern gegen hba1c.
ITRM920506A1 (it) Regioni antigeniche dei complessi tpl e anticorpi diretti contro di essi.
ATE286509T1 (de) Interferon alpha/beta bindendes protein, seine herstellung und anwendung